about
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting ...
Read More
0.98
-0.10
(-9.26%)
1.3M
XNAS Volume
XNAS 29 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Immunic Inc is on 08 Aug 2025 for the purpose of Immunic Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Immunic Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..